B R Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 24-05-2024
- Paid Up Capital ₹ 1.00 Cr
as on 24-05-2024
- Company Age 30 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.09 Cr
as on 24-05-2024
About B R Laboratories
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹4.09 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Janmejay Vyas, Deohooti Vyas, and Aditi Vyas serve as directors at the Company.
- CIN/LLPIN
U23209GJ1994PLC022124
- Company No.
022124
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 May 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at B R Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditi Vyas  | Director | 01-Dec-1997 | Current |
| Janmejay Vyas | Director | 26-May-1994 | Current |
| Deohooti Vyas | Director | 26-May-1994 | Current |
Financial Performance and Corporate Structure Insights of B R Laboratories.
B R Laboratories Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of B R Laboratories?
In 2017, B R Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dishman Carbogen Amcis LimitedActive 17 years 5 monthsJanmejay Vyas and Deohooti Vyas are mutual person
- Dishman Biotech LimitedActive 29 years 1 month
Janmejay Vyas, Deohooti Vyas and 1 more are mutual person
- Dishman Infrastructure LimitedActive 18 years 5 months
Janmejay Vyas and Aditi Vyas are mutual person
- Rtv Technochem Private LimitedActive 3 years 2 months
Janmejay Vyas and Deohooti Vyas are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Karur Vysya Bank Limited Creation Date: 28 Jun 2003 | ₹2.05 Cr | Satisfied |
The Karur Vysya Bank Limited Creation Date: 07 Jan 2003 | ₹2.05 Cr | Satisfied |
How Many Employees Work at B R Laboratories?
Unlock and access historical data on people associated with B R Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B R Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B R Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
